Deconstructing the drug development process // Drug Repurposing

Deconstructing the drug development process

Photo.jpg

June’s SHOW will examine the drug development process and highlight new paradigms for pharmaceutical innovation. In the current pharmaceutical research-based drug industry, the source of many of the ...

June’s SHOW will examine the drug development process and highlight new paradigms for pharmaceutical innovation. In the current pharmaceutical research-based drug industry, the source of many of the medications in use today, economic, regulatory, and competitive pressures are forcing companies to re-evaluate and restructure their research and development (R&D) processes. Our special guest speaker Dr. Kenneth Kaitin will discuss major shifts within the pharmaceutical industry. The industry has been undergoing a transformation from fully-integrated pharmaceutical companies (FIPCos) to a network model (FIPNet) that encompasses all the major stakeholders in drug development including: large and small pharmaceutical and biotechnology companies, academic research institutions, patient groups, public-private-partnerships, and contract research organizations.

Views

Total Views 736 Views on SlideShare 736 Embed Views 0

Actions

Likes 1 Downloads 0

You might also like

Lupus Drug Development
Lupus Drug Development
The challenges of oncology drug development (part 1)
The challenges of oncology drug development (part 1)

Latin American Leaders oppose plan colombia

by jnc

Over 100 Top Latin American Leaders Call on President Bush to Halt “Plan Colombia” at Upcoming Summit of the Americas
President George W. Bush
United States of America
April 16, 2001
Dear President Bush,
As your Administration considers the future direction of U.S. policy towards the Andes, we ask you to suspend and reformulate US support for the implementation of Plan Colombia, placing a greater emphasis on supporting the peace process.
We, the undersigned Latin Americans, know there are no easy answers or quick fixes to Colombia's tragic dilemma of warfare and drug related violence

How Technology Will Defeat Terrorism

by tisktisk

In transit across Manhattan on any given day are some 4 million letters, 3 million people, half a million motor vehicles and their contents, and half a million parcels—any of which may be carrying something lethal. Step by step, cities like New York must now learn to watch and track everything that moves. Airport screening is coming to much of the rest of civilian life; but it will have to be much smoother, faster, more accurate screening than airports have today, or life will just grind to a halt.
However much local governments may yearn for a one-stop federal solution to their new security problems, much of the initiative and innovation will almost certainly be left to them

Peoples Bark News Berkeley

by johnvance

Please visit for news. There are also very good IRCchat rooms that could be utilized.
PBNB Editor
========================================
========================================
Celebrate Black History and Womyn's Herstory every day!
=============================
PRUNE the SHRUB!
ILLEGITIMATE SONOFABUSH!
These ARE available buttons/stickers - check out how to get em' at our
website! all news flashes to
aliun@hotmail.com for publication.
=================
'THERE IS NO WAY TO PEACE, PEACE IS THE WAY' --- A.J. Muste
===============
===============
If you believe that Peoples Bark News Berkeley is an invaluable contribution and an asset to the community, please consider making a donation. We are not tax-deductible. You must make checks out to:
john vance, c/o A First Amendment Center and mail to:
A First Amendment Center
PO Box 48…

Wiley Flow Cytometry in Drug Discovery and Development
Book (Wiley)

The Morning Ledger: Companies Look to Turn the Tables on Proxy Advisers  — Wall Street Journal
Astra cited the potential value of its cancer drugs in development as one of the reasons for rejecting the approach. Tesla's Musk plans to remain CEO into 2018.